Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Sarepta Therapeutics

5 Disclosed Funding Rounds $879,999,980

4 Participating Investments $90,000,000


Therapeutics, Health Care, Genetics, Biotechnology

Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.

Cambridge, Massachusetts, United States, North America (US)

Organizations in Cambridge in Therapeutics,
Organizations in Cambridge in Health Care,
Organizations in Cambridge in Genetics,
Organizations in Cambridge in Biotechnology,
Organizations in Massachusetts in Therapeutics,
Organizations in Massachusetts in Health Care,
Organizations in Massachusetts in Genetics,
Organizations in Massachusetts in Biotechnology,
Organizations in United States in Therapeutics,
Organizations in United States in Health Care,
Organizations in United States in Genetics,
Organizations in United States in Biotechnology,
Organizations in North America in Therapeutics,
Organizations in North America in Health Care,
Organizations in North America in Genetics,
Organizations in North America in Biotechnology

Investors in Cambridge in Therapeutics,
Investors in Cambridge in Health Care,
Investors in Cambridge in Genetics,
Investors in Cambridge in Biotechnology,
Investors in Massachusetts in Therapeutics,
Investors in Massachusetts in Health Care,
Investors in Massachusetts in Genetics,
Investors in Massachusetts in Biotechnology,
Investors in United States in Therapeutics,
Investors in United States in Health Care,
Investors in United States in Genetics,
Investors in United States in Biotechnology,
Investors in North America in Therapeutics,
Investors in North America in Health Care,
Investors in North America in Genetics,
Investors in North America in Biotechnology

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 1980

Founders Marwan Fawaz, James Summerton

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as AVI Biopharma, Antivirals, Sarepta

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.

Date Round Raised Lead
February, 14, 2020 Post-IPO Equity $399,999,980 -------
December, 13, 2019 Post-IPO Debt $250,000,000 Pharmakon Advisors
October, 23, 2018 Post-IPO Equity $90,000,000 -------
July, 19, 2017 Post-IPO Debt $100,000,000 MidCap Financial
June, 26, 2015 Post-IPO Debt $40,000,000 -------

Sarepta Therapeutics Participated In the Following Investment Rounds (4)

Organization Name Lead? Round Partners Participating Raise Date
StrideBio No Series B ------- $81,500,000 March, 16, 2021
AavantiBio No Series A ------- $107,000,000 October, 22, 2020
Lacerta Therapeutics Yes Venture - Series Unknown ------- $30,000,000 August, 09, 2018
Myonexus Therapeutics Yes Corporate Round ------- $60,000,000 May, 08, 2018

Sarepta Therapeutics Investors (3)

Investor Lead? Round Participating Raise Date Partners
Roche Financial No Post-IPO Equity $399,999,980 February, 14, 2020 -------
Pharmakon Advisors Yes Post-IPO Debt $250,000,000 December, 13, 2019 -------
MidCap Financial Yes Post-IPO Debt $100,000,000 July, 19, 2017 -------